WUXIAN
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97748717
- Registration number
- 7357188
- Mark type
- Stylized text
- Filed
- 10 Jan 2023
- Published for opposition
- 14 Nov 2023
- Registered
- 09 Apr 2024
- Attorney of record
- Michael T. Smith
Goods and services
- Class 042 — Scientific and technological services: Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies
Owner
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, CO LOUTH, IE
Prosecution history
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jan 2024 — USE AMENDMENT FILED
- 22 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 09 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Oct 2023 — ASSIGNED TO EXAMINER
- 01 Feb 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED